Director of Product Marketing, Microarray Genotyping, Thermo Fisher Scientific
BIOGRAPHY
JUN 22, 2020 7:00 AM PDT
Host Genetics with the new Axiom™ Human Genotyping SARS-CoV-2 Research Array
Speaker
Event Date & Time
DATE: June 22, 2020
TIME: 7:00am PT, 10:00am ET
Abstract
This is the first topic in the webinar series on ‘Predictive Genomics for Population & Personalized Health’.
A major challenge for healthcare providers and geneticists is to learn how SARS-CoV-2, the coronavirus that causes the COVID-19 disease, interacts with the human genome and to stratify populations in order to understand disease susceptibility, severity, and outcomes.
For such studies in predictive genomics, we are launching the Applied Biosystems™ Axiom™ Human Genotyping SARS-CoV-2 Research Array with a COVID-19 research module covering various genes and pathways such as ACE2, TMPRSS2, and the NOTCH pathway that are implicated in SARS-CoV-2 host genetics. In addition, the array has a large GWAS module (>820,000 markers) that can serve to conduct association studies to understand the interactions with underlying conditions including COPD, cardiovascular disease, and kidney disease, and to help identify targets that can be treated with drugs.
Learning Objectives:
- Extend epidemiological research to host genetics to study SARS-CoV-2 infectious disease
- Review whole genome technology purpose to stratify populations by risk to manage disease
- Choose a new whole-genome array for SARS-CoV-2 infection research
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
You May Also Like
DEC 10, 2024 | 9:00 AM
To-date, proteomic analysis has been severely limited in scale and resolution. Analyzing protein samples using an intact, single-molecule approach holds th...
OCT 02, 2024 | 7:30 AM
De novo gene synthesis and protein expression are established technologies that can give access to nearly any target DNA or protein sequence, allowing for engineering of biologics. In this p...
Loading Comments...